FDA Warning: Cardinal Health Monject Syringes Recall and Incompatibility Concerns

2023-11-21 03:18:56

The US Food and Drug Administration has warned healthcare providers and medical facilities once morest using Monject syringes produced by Cardinal Health.

The administration’s warning comes following the company began recalling Monject syringes over concerns regarding incompatibility between its parts.

Monject syringes are used to introduce or withdraw fluids into the body, while patient-controlled pain management pumps are used to treat different types of pain by delivering medications intravenously.

In June, the company began selling the new Monject syringes, which feature different dimensions compared to the company’s previous versions known as Covidien.

The administration said today that Covidien syringes can be used and that it will work with the company to conduct further evaluations of the problem that appeared in the new syringes.

1700560941
#American #warning #syringes #produced #Cardinal #Health

Leave a Replay